Horne GA, Stobo J, Kelly C, Mukhopadhyay A, et al. A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease. Leukemia 2020;34:1775-1786.
PMID: 31925317